摘要
目的:评析羟乙基淀粉加尤瑞克林在急性脑梗死治疗中的临床效果。方法:收治急性脑梗死患者104例,分两组,各52例,两组均贯彻基线治疗与尤瑞克林用药,试验组同时还配合羟乙基淀粉治疗,分析临床效果。结果:各组治疗前后评分均获得改善,试验组的改善更显著(P<0.05);试验组的临床总好转率94.2%,高于对照组的73.1%(P<0.05)。结论:羟乙基淀粉加尤瑞克林在急性脑梗死治疗中治愈率高,患者的神经功能和生活能力可获得显著提升。
Objective:To discuss the clinical effect of hydroxyethyl starch to urinary kallidinogenase in the treatment of acutecerebral infarction.Methods:104 patients with acute cerebral infarction were selected.They were divided into two groups,52 casesin each.Two groups were carried out baseline and treatment of urinary kallidinogenase treatment.The experimental group is also inline with hydroxyethyl starch in the treatment.We analyzd the clinical effect.Results:Before and after treatment,the scores wereimproved,and the improvement of the experimental group was more significant(P<0.05).The clinical total improvement rate was94.2%,higher than that of the control group of 73.1%(P<0.05).Conclusion:Hydroxyethyl starch with urinary kallidinogenase intreatment of acute cerebral infarction has high cure rate.Patients with nerve function and living ability can be enhanced obviously.
作者
孙迎男
朱艳春
孙立明
许晗
Sun Yingnan;Zhu Yanchun;Sun Liming;Xu Han(Department of Neurology,the Second Hospital of General Hospital of Jilin Chemical Group Company 132021)
出处
《中国社区医师》
2016年第16期26-26,28,共2页
Chinese Community Doctors
关键词
羟乙基淀粉
尤瑞克林
急性脑梗死
Hydroxyethyl starch
Urinary kallidinogenase
Acute cerebral infarction